)
Edge31 Oct 2025
Rolls-Royce: Full Thrust Ahead
From century-old crafted perfection to pandemic shock and reset, Rolls-Royce's story is shaped by heritage, turbulence, and a disciplined climb back.
OssDsign (OSSD) investor relations material
OssDsign Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary4 Nov, 2025
Executive summary
Achieved record sales in Q3 2025 with SEK 44 million, up 35% year-over-year at constant currency and 23% reported, despite seasonality and currency headwinds.
Underlying quarter-over-quarter growth was 5% after adjusting for a $1.5M sales shift and currency effects.
Launched and began executing the 'Scaled to Profit' growth strategy, focusing on doubling the US sales force and expanding into adjacent orthopedic segments.
CEO transition announced, marking transformation from EU-centric to high-growth US-focused orthobiologics company.
Strategic focus on expanding the sales team, launching new products, and shifting manufacturing to the U.S. to drive growth and profitability.
Financial highlights
Q3 net sales: SEK 44,020k (Q3 2024: SEK 35,728k); nine months: SEK 135,036k (2024: SEK 92,494k).
Organic growth of 35% year-over-year for the quarter (constant currency), 23% reported due to USD headwinds.
Gross margin at 95.6% in Q3, slightly down due to mix and currency, but well above the 93% guidance.
Q3 adjusted EBIT: SEK -5,319k (Q3 2024: SEK -9,835k), best in company history, driven by strong operating leverage.
Cash and cash equivalents at period end: SEK 210.9 million.
Outlook and guidance
Targeting sales over SEK 400 million by 2028, with positive operating result and cash flow in the latter half of the strategy period.
Plans to double the sales team by 2026 and launch two new products, with an MIS solution in 2026 and a hydrophilic strip product between 2027-2028.
Large randomized controlled trial to start in the second half of 2026.
Manufacturing shift to the U.S. expected to improve cost-effectiveness and scalability.
Ongoing focus on cost efficiency and further gross margin improvement.
Timeline for positive operating cash flow?
Plans for Catalyst in non-spine indications?
Underlying Q3 growth drivers, excluding distortions?
Expected sales contribution from new US reps?
Cost of planned Level 1 RCT?
How will US production impact gross margin?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next OssDsign earnings date
Q4 202510 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
OssDsign AB designs, manufactures, and sells implants and material technology for bone regeneration. The company's products are used to treat bone defects in the hard palate and other areas as well as to support dental implants. The company has strategic relations with several companies across Europe and the US, and markets their products to customers all over the world. OssDsign's aim is to be an innovative and leading specialty pharma player within the fast growing bone reconstruction market by providing products that offer unique opportunities for superior clinical outcomes, thereby adding value for patients, healthcare providers and investors.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage